Hanmi Financial (HAFC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). As U.S. markets show signs of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Hanmi Financial Stock Up 1.6 % Hanmi Financial stock opened at $22.46 on Friday. The stock has a 50-day simple moving average of $23.29 and a 200-day simple moving average of $22.73. The company ...

SEOUL, South Korea, March 20, 2025 /CNW/ - Hanmi Pharmaceutical Co., Ltd. (the "Company") announced today that, on March 19, 2025, the Company acquired 409,063 common shares (the "Acquired Shares ...

Roche’s Genentech unit is to partner with South Korea’s Hanmi Pharmaceutical, to develop and market a phase 1 cancer drug, in a deal potentially worth over $900 million. Under the agreement ...

Furthermore, the two companies have amended their existing Investor’s Rights Agreement. Hanmi, holding at least 10% of Aptose’s outstanding shares, will now enjoy enhanced rights under Rule ...